Prenatal Genetic Testing and Screening for Expecting Parents

Prenatal genetic testing is a set of choices, not a single required step. This guide covers how to decide whether to test, what test accuracy really means, what carrier screening adds, how to weigh a diagnostic procedure, and which questions to ask when results arrive.

The moment when your pregnancy test kit shows the second line pink, you enjoy this with laughter and emotions. Then your brain thought about different questions. The first thought on every parent’s mind is whether their baby is healthy or not. Prenatal genetic testing and screening provide early insights, helping ease concerns safely, though no test is flawless. These test gives you a clearer picture of your baby’s health before birth.

One moment, here’s the truth: these tests are optional, not obligatory but satisfactory. They are methods where you find the risks like chromosomal changes or genetic disorders. If a serious condition is identified, parents and doctors can plan for specialized care at birth. For many, a “low risk” result reduces anxiety and helps expectant parents with confident.

What Is Prenatal Genetic Testing and Screening

Prenatal testing is all about gathering samples, like blood or fluid, to analyze prenatal samples for clues. This helps spot issues early, often in the first or second trimester. Prenatal genetic testing and screening refer to two different types that check for genetic disorders or birth abnormalities before your baby is born. Many parents are confused about screening and diagnostic tests. Let’s clear these tests:

• Screening tests: Estimate the risk that the fetus has a chromosomal/genetic problem. It doesn’t give you a final diagnosis
• Diagnostic tests (Invasive): Confirm if a genetic disorder is present or not. It is invasive (CVS, amniocentesis)

According to the American College of Obstetricians and Gynecologists (ACOG), these tests analyze chromosomes (the threadlike structures holding your genes) or specific genes to detect conditions like Down syndrome, cystic fibrosis, or spinal muscular atrophy.

First Trimester Screening: Weeks 10-13

1. Cell-free fetal DNA testing (NIPT/cfDNA):

The most talked-about advancement analyzes tiny fragments of your baby’s DNA floating in your bloodstream. Performed after 10 weeks of gestation, it screens for trisomy 21 (Down syndrome), trisomy 18, and trisomy 13.

Depending on which laboratory runs it, the panel may also screen for:

• Sex chromosome conditions
• Certain microdeletions

Remember that cell-free DNA testing is a screening test, not a diagnosis. A high-risk result always needs confirmatory diagnostic testing before any decision is made.

2. Nuchal translucency screening:

It uses ultrasound to measure the fluid at the back of your baby’s neck. This happens between 11-14 weeks.

Thickened NT can indicate:

• Chromosomal abnormalities
• Heart defects
• Some genetic syndromes

3. Serum screening (PAPP-A & β-hCG)

It measures specific proteins in your blood that indicate chromosomal differences. It’s less precise than NIPT but:

• Affordable
• Widely available
• Useful when NIPT is not accessible

Cell-free DNA screening can also reveal your baby’s biological sex early in the pregnancy, a detail some parents love and others prefer to skip. Tell your provider in advance if you would rather not be told.

Second Trimester Screening: Weeks 15-22

1. Quad screening:

It examines four substances (AFP, hCG, Estriol, Inhibin-A) in your blood to assess risk for neural tube defects, trisomy 21, and trisomy 18. Often done for people who:

• Missed first-trimester screening
• Don’t choose NIPT
• Need additional risk assessment

2. AFP screening (alpha-fetoprotein):

It specifically checks for neural tube defects like spina bifida, other neural tube defects, and abnormal wall defects. Your provider draws blood between 15-22 weeks to measure these levels

3. Fetal anatomy scan:

The detailed 20-week ultrasound examines the fetus’s anatomy, including:

• Brain
• Heart
• Kidneys
• Limbs
• Organs
• Spine

It’s a routine part of prenatal testing that every pregnancy includes, not just high-risk ones.

The Cleveland Clinic notes that this scan can identify physical abnormalities that might indicate underlying genetic conditions, even when chromosomes appear normal.

Prenatal Diagnostic Tests to Find Definitive Answers

If screening tests show an elevated risk or if you have a known family history of genetic conditions, prenatal testing for genetic diseases enters its second phase: diagnostic testing.

1. Chorionic Villus Sampling (CVS) (10-13 weeks)

• CVS is performed earlier than amniocentesis by sampling a tiny piece of placental tissue.
• It provides earlier results but carries a slightly higher miscarriage risk than amniocentesis.

2. Amniocentesis (16-20 weeks)

• This test uses a thin needle to collect a small sample of the amniotic fluid surrounding your baby.
• The sample contains fetal cells, allowing laboratories to confirm chromosomal conditions with more than 99% accuracy.

According to the Cleveland Clinic, both procedures carry a small risk of complications like miscarriage, which is why they are recommended only when the results would meaningfully guide your care or decisions.

Who Should Consider Prenatal Genetic Testing

You should strongly consider prenatal genetic testing if:

Couples with a family history of genetic disorders – If either parent has relatives with inherited conditions like cystic fibrosis, Tay-Sachs, or sickle cell anemia.

Previous pregnancy with a genetic abnormality – Parents who have had a child with a genetic disorder or experienced miscarriages due to chromosomal issues.

Known carrier of a genetic disorder – Either parent has been identified as a carrier through genetic testing.

Women over 35 years old – Advanced maternal age increases the risk of chromosomal abnormalities such as Down syndrome.

Abnormal prenatal screening results – Blood tests or ultrasounds indicating a higher likelihood of genetic conditions.

Parents of different ethnic backgrounds – Certain genetic disorders are more prevalent in specific ethnicities, so mixed heritage increases the value of testing.

For your information: The Mayo Clinic Health System reports that carrier screening is a one-time test. If you plan multiple pregnancies, getting screened once gives you lifelong insight for future family planning.

Prenatal tests look at your baby. Separately, pharmacogenomic (PGx) testing looks at how your own body processes certain medicines. The RPh Labs at-home cheek swab reports on 240+ medications for the adult who takes the test. It is not a prenatal or fetal test, it does not screen your baby, and any medication decision in pregnancy belongs with your own prescriber.

Understanding False Positives and False Negatives

No prenatal genetic test is perfect.

• False positives (test shows high risk but baby is healthy) do happen, and they often lead to anxiety and to invasive follow-up tests that turn out not to have been needed.
• False negatives (test shows low risk but baby has the condition) are much rarer, but still possible.

In April 2022, the US. Food and Drug Administration (FDA) issued a safety communication warning that some non-invasive prenatal screening tests can produce false results.

Pro Tip:

Always confirm abnormal results with diagnostic testing before making irreversible decisions.

The Timeline: When to Do What

Gestational Age	Test Type	What It Screens For
10+ weeks	Cell-free DNA (NIPT)	Trisomy 21, 18, 13; fetal sex
11-14 weeks	Nuchal translucency	Chromosomal & heart defects
11-13 weeks	CVS (diagnostic)	Confirms chromosomal conditions
15-22 weeks	Quad/AFP screening	Neural tube defects
16-20 weeks	Amniocentesis	Confirms chromosomal conditions
18-20 weeks	Anatomy scan	Structural abnormalities

What Happens Next After the Results

If Results Are Normal

• You can breathe easier, but remember, no test detects every condition.
• Continue regular prenatal care, and keep your provider updated on new symptoms or on anything new you learn about your family history.

If Results Are Abnormal

Your provider will recommend genetic counseling.

A counselor will:

• Review your family history
• Explain what the results truly mean
• Help you decide on diagnostic testing (if not already done)
• Discuss your options moving forward

After an abnormal screen, some parents choose diagnostic testing for a definite answer, while others choose targeted ultrasounds and close monitoring instead. Both are reasonable, and a genetic counselor can help you weigh them.

How to decide whether prenatal genetic testing is right for you

The hardest part of prenatal genetic testing is usually not the blood draw. It is deciding in advance what you would do with each possible answer, because that is what makes a result useful instead of frightening.

Before you say yes or no, it helps to answer three questions for yourself:

1. Would a higher-risk result change anything about your pregnancy care, your birth plan, or where you deliver?
2. Would you want a diagnostic procedure to confirm a screening result, or would you prefer to stop at screening?
3. Would you rather know early, know late, or not know at all?

There is no wrong set of answers. Some parents want every piece of information available. Others decline screening entirely and keep standard prenatal care, and that is a legitimate choice your clinician should support without pressure.

One thing worth knowing is that declining now does not close the door. Most options have a window rather than a single day, and a few, including the anatomy ultrasound, are part of routine care regardless. Ask your obstetric team to sketch the calendar for your pregnancy so you can see which decisions are due when.

If any part of the conversation feels rushed, ask for a referral to a genetic counselor before you consent. That visit is the point at which prenatal genetic testing turns from a menu into a plan.

What nipt test accuracy really means

Nipt test accuracy is the most misread number in pregnancy. Laboratories usually advertise detection rate, which is how often the test flags a pregnancy that truly has the condition. That is not the number you need when a result comes back high risk.

Detection rate versus positive predictive value

The number that matters after a high-risk result is the positive predictive value, which is the chance that the finding is real for you. It depends on how common the condition is in people like you, so it is higher for Down syndrome than for rare trisomies and microdeletions, and it rises with maternal age.

That is why cell-free DNA is described as a screen. A high-risk result is a reason for a conversation and usually a diagnostic test, not a diagnosis. Ask the laboratory report for the positive predictive value for your specific result rather than the headline detection rate.

Other things that affect nipt test accuracy

• Low fetal fraction, when too little fetal DNA is present, which may mean a redraw rather than a result.
• Twins, where interpretation is more limited.
• Vanishing twin or an unrecognized maternal condition, which can produce a misleading signal.
• Rare conditions, where nipt test accuracy for prediction is lowest even when detection is good.

None of this means the test is unreliable. It means it answers a probability question, and knowing that in advance saves a lot of distress in the week after a phone call.

What carrier screening covers and when to do it

Carrier screening looks at the parents, not the fetus. It checks whether you carry a single copy of a gene change for a recessive condition such as cystic fibrosis, sickle cell disease, spinal muscular atrophy or Tay-Sachs disease. Carriers are usually healthy and often have no family history at all.

Because recessive conditions need two copies, the question is whether both partners carry a change in the same gene. That is why the useful order is to screen one partner first, then screen the second partner for anything found.

Timing

The best time for carrier screening is before pregnancy, because it leaves the widest range of options open, including planning, donor choices or in vitro fertilization with embryo testing. It can still be done during pregnancy, and results can guide whether diagnostic testing is offered.

Panels differ a great deal in size. A targeted panel may read a handful of genes, while an expanded panel may read hundreds. Bigger is not automatically better, since more genes mean more carrier results to interpret and more uncertainty, so ask what your panel covers and what a negative result does not rule out.

One practical advantage is that carrier screening is generally a one-time test on your own DNA, so a result you keep can inform later pregnancies too. Keep a copy of the report, not just the summary text message.

Amniocentesis risks and how to weigh them

Amniocentesis and chorionic villus sampling are diagnostic, meaning they read fetal cells directly and give a definite answer about the chromosomes or genes examined. Because they are procedures, they carry small risks that screening blood tests do not.

When people ask about amniocentesis risks, the honest answer has three parts. The risk of pregnancy loss attributable to the procedure is small in experienced hands, minor symptoms such as cramping or fluid leakage occur in a minority of people, and infection is uncommon. Your own maternal-fetal medicine clinician should quote you their center’s figures rather than a number from the internet.

• Ask how many of these procedures the operator performs each year.
• Ask whether ultrasound guidance is used throughout, which is standard.
• Tell them your blood type, since Rh-negative patients may be offered Rh immune globulin.
• Ask which symptoms after the procedure should prompt a call, and which need urgent care.

Weighing amniocentesis risks means weighing them against the value of a definite answer. If a confirmed diagnosis would change where you deliver, who is in the room, or the care your baby receives in the first hours of life, that answer can be worth a great deal. If it would change nothing, it is reasonable to decline.

Timing also differs. Chorionic villus sampling happens earlier in pregnancy than amniocentesis, which is why the choice between them is usually driven by how many weeks along you are when the question comes up.

Questions to ask when prenatal screening results come back

Phone calls about prenatal screening results are short and easy to misremember. Keep this list somewhere you can reach it quickly.

1. Was this a screening test or a diagnostic test?
2. What exactly was reported, and for which condition?
3. What is the positive predictive value for this result, given my age?
4. What are my options to confirm it, and what is the deadline for each?
5. Can I see a genetic counselor this week?
6. Can I have a copy of the full laboratory report?

Ask for the report in writing. Prenatal screening results are often summarized as low risk or high risk, and the detail underneath, including which conditions were and were not examined, is what a second clinician will need.

It is also fine to take a pause. Except where a procedure has a timing window, you rarely have to decide the same day. Bring someone with you to the follow-up visit, and write the answers down while you are still in the room.

If prenatal screening results are reassuring, keep them in perspective. A low-risk screen lowers the probability of the specific conditions examined. It is not a statement that a baby is healthy, which is why the anatomy ultrasound and routine prenatal care continue as planned.

Cost, coverage and consent

Money is part of this decision and nobody should feel awkward raising it. Coverage for prenatal genetic testing varies widely by plan, by state and by whether the test is considered medically indicated, so the only reliable answer comes from asking before the sample is collected.

• Ask for the CPT codes the clinic will bill and the name of the laboratory.
• Ask whether that laboratory is in network for your plan.
• Ask what the self-pay price is if the claim is denied, and whether financial assistance exists.
• Ask whether prior authorization is needed, and who submits it.

Consent deserves the same attention. Ask what happens to the sample after testing, whether it is stored, whether it may be used for research, and how to opt out. Laboratories differ, and the answer should be in the consent form you sign.

It is also worth asking whether a result will be recorded in your medical record and who else will see it. Most parents are comfortable with this, but you are entitled to understand it in advance rather than afterwards. Our insurance page explains how benefit checks work for laboratory testing in general.

What prenatal genetic testing cannot tell you

Being clear about the edges of these tests protects you from both false comfort and needless worry. Prenatal genetic testing examines specific chromosomes and specific genes, and it is silent about everything outside that list.

It cannot predict autism, intelligence, personality or temperament. It cannot rule out most of the thousands of rare genetic conditions unless a specific condition was targeted because of family history or an ultrasound finding. It cannot detect problems that develop later in pregnancy or after birth.

It also says nothing about medications. A separate kind of test, pharmacogenomic (PGx) testing, reads genes that affect how a person processes certain medicines. It is done on the parent, not the fetus, it does not diagnose disease, and it does not predict whether anyone will develop a condition.

The RPh Labs 20-gene panel is that second kind of test. It is not a prenatal test, it does not screen a fetus, and it does not include the chromosomes or genes read in prenatal screening. If you want to know how the two differ, our guide to what PGx testing is lays it out plainly.

You can read a general explanation of pharmacogenomics from MedlinePlus if you want a neutral source.

Medication questions that come up around pregnancy

Many parents already take a medicine when they become pregnant, or need one during pregnancy or after delivery. Those questions belong with the prescriber and the obstetric team, and they are not answered by prenatal genetic testing.

Never stop, start, split or change a prescription on your own because of something you read, including a gene report. Stopping some medicines abruptly can be dangerous, and for several psychiatric medicines the risks of untreated illness in pregnancy are real too. Ask for a plan instead.

Where gene information genuinely helps is narrower than marketing suggests. CYP2C19 and CYP2D6 affect how the body handles several antidepressants, and CYP2D6 converts codeine and tramadol into their active forms, which is why those two are approached cautiously in breastfeeding. Published gene and drug pairs are listed by CPIC.

Pregnancy itself changes drug handling. Blood volume, kidney clearance and enzyme activity all shift across trimesters, and other medicines can block an enzyme regardless of genotype. A gene result is one input among several, alongside kidney and liver function, dose history and what has worked for you before.

If a PGx report would help those conversations, RPh Labs offers an at-home cheek swab kit and every report is reviewed by a PharmD pharmacist. Results reflect genes that do not change over your lifetime, so the report stays useful long after the pregnancy.

Conclusion

Prenatal genetic testing and screening offer powerful insights, but they should never feel like a requirement. The decision is entirely yours. Whether you choose every option or none at all, your choice deserves respect.

Prenatal testing informs one chapter of your baby’s health story. A pharmacogenomic test is a separate and different thing: it reports how you, the adult taking it, process certain medicines. It does not screen your baby and it does not diagnose any condition, but the report can help your own prescriber and pharmacist choose medicines for you.

Sources:

• Cleveland Clinic: Chronic Villus Sampling For Prenatal Diagnosis
• Cleveland Clinic: Genetic Amniocentesis
• Mayo Clinic Health System: Carrier Screening for Family Planning

Disclaimer:

This material is intended for general information only and does not replace medical consultation. Consult your healthcare provider regarding your pregnancy. Some visuals used here are AI-generated for demonstration purposes.

Prenatal genetic testing FAQ

What’s the difference between a prenatal panel and a pregnancy genetics test?

A prenatal panel typically combines multiple screenings (blood tests, ultrasound) into one package. A pregnancy genetics test usually refers to specific gene or chromosome analysis. Always ask your provider exactly what’s included.

Can I do prenatal genetic testing at home?

No. All prenatal genetic testing and screening require blood draws or ultrasounds at medical facilities.

How accurate is NIPT?

For Down syndrome, NIPT detects over 99% of cases with less than 1% false positives. But accuracy drops for rarer conditions like trisomy 13. Confirmatory testing is crucial.

Will testing tell me if my baby will have autism?

No current prenatal tests can predict autism spectrum disorder. Genetic testing focuses on chromosomal conditions and specific genetic disorders with known markers.

What happens to my DNA samples after testing?

Labs vary. Some discard prenatal samples after testing; others store them for research (with consent).

Is carrier screening the same as testing my baby?

No. Carrier screening reads the parents’ DNA to see whether you carry a change for a recessive condition. It says nothing directly about the fetus. If both partners carry a change in the same gene, your clinician may then offer testing of the pregnancy itself, either by chorionic villus sampling or amniocentesis.

If nipt test accuracy is over 99 percent, why do I need another test?

Because that figure is the detection rate, not the chance a high-risk result is correct for you. The chance it is real, called positive predictive value, depends on how common the condition is and on your age. That is why a high-risk screen is normally confirmed with a diagnostic test before any irreversible decision.

How soon after a high-risk screen should I decide about amniocentesis risks?

Ask your clinician for the timing window rather than deciding on the call. Chorionic villus sampling is offered earlier in pregnancy than amniocentesis, so the option available depends on how many weeks along you are. Use the days in between to see a genetic counselor and to get the procedure figures from the center that would perform it.

Can I do any of this testing at home?

No. Prenatal screening needs a blood draw and ultrasound, and diagnostic testing is a clinic procedure. At-home kits exist for pharmacogenomic testing, which reads an adult’s own medication-processing genes, but that is a different test with a different purpose and it does not assess a pregnancy.

Who explains prenatal screening results if my obstetrician is busy?

Ask for a referral to a genetic counselor, who is trained specifically for this conversation. Many programs offer telehealth appointments, so access no longer depends on living near a large medical center. Bring the full laboratory report, your family history and a written list of questions to that visit.

Does a normal result mean my baby is healthy?

Not quite. It means the specific conditions examined were not flagged. Many conditions are outside the panel, and some problems appear later in pregnancy or after birth. That is why the anatomy ultrasound, routine prenatal visits and newborn screening after delivery all continue regardless of a reassuring screen.